298 related articles for article (PubMed ID: 30151947)
1. Adjuvant Chemotherapy Is Associated With Improved Survival for Late-Stage Salivary Squamous Cell Carcinoma.
Cheraghlou S; Schettino A; Zogg CK; Otremba MD; Bhatia A; Park HS; Osborn HA; Mehra S; Yarbrough WG; Judson BL
Laryngoscope; 2019 Apr; 129(4):883-889. PubMed ID: 30151947
[TBL] [Abstract][Full Text] [Related]
2. Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma: Data From the National Cancer Data Base.
Amini A; Waxweiler TV; Brower JV; Jones BL; McDermott JD; Raben D; Ghosh D; Bowles DW; Karam SD
JAMA Otolaryngol Head Neck Surg; 2016 Nov; 142(11):1100-1110. PubMed ID: 27541166
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemoradiotherapy versus with radiotherapy alone for locally advanced salivary gland carcinoma among older patients.
Tanvetyanon T; Fisher K; Caudell J; Otto K; Padhya T; Trotti A
Head Neck; 2016 Jun; 38(6):863-70. PubMed ID: 26340707
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive comparative analysis of treatment modalities for sinonasal malignancies.
Robin TP; Jones BL; Gordon OM; Phan A; Abbott D; McDermott JD; Goddard JA; Raben D; Lanning RM; Karam SD
Cancer; 2017 Aug; 123(16):3040-3049. PubMed ID: 28369832
[TBL] [Abstract][Full Text] [Related]
5. Can chemotherapy boost the survival benefit of adjuvant radiotherapy in early stage cervical cancer with intermediate risk factors? A population based study.
Mahmoud O; Hathout L; Shaaban SG; Elshaikh MA; Beriwal S; Small W
Gynecol Oncol; 2016 Dec; 143(3):539-544. PubMed ID: 27769525
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant therapy in major salivary gland cancers: Analysis of 8580 patients in the National Cancer Database.
Cheraghlou S; Kuo P; Mehra S; Agogo GO; Bhatia A; Husain ZA; Yarbrough WG; Burtness BA; Judson BL
Head Neck; 2018 Jul; 40(7):1343-1355. PubMed ID: 29756412
[TBL] [Abstract][Full Text] [Related]
7. Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption.
Li H; Torabi SJ; Park HS; Yarbrough WG; Mehra S; Choi R; Judson BL
Laryngoscope; 2019 Aug; 129(8):1844-1855. PubMed ID: 30575965
[TBL] [Abstract][Full Text] [Related]
8. Survival advantage associated with multimodal therapy in women with node-positive (stage-IIIC) uterine papillary serous carcinoma: a National Cancer Database study.
Lin JF; Muñiz K; Sukumvanich P; Gehrig P; Beriwal S; Kelley JL; Edwards RP; Olawaiye AB
BJOG; 2016 Oct; 123(11):1846-52. PubMed ID: 26537059
[TBL] [Abstract][Full Text] [Related]
9. Triple-modality treatment in patients with advanced stage tonsil cancer.
Roden DF; Schreiber D; Givi B
Cancer; 2017 Sep; 123(17):3269-3276. PubMed ID: 28440876
[TBL] [Abstract][Full Text] [Related]
10. Patterns of care and survival of adjuvant radiation for major salivary adenoid cystic carcinoma.
Lee A; Givi B; Osborn VW; Schwartz D; Schreiber D
Laryngoscope; 2017 Sep; 127(9):2057-2062. PubMed ID: 28194862
[TBL] [Abstract][Full Text] [Related]
11. Pediatric Salivary Cancer: Epidemiology, Treatment Trends, and Association of Treatment Modality with Survival.
Morse E; Fujiwara RJT; Husain Z; Judson B; Mehra S
Otolaryngol Head Neck Surg; 2018 Sep; 159(3):553-563. PubMed ID: 29688836
[TBL] [Abstract][Full Text] [Related]
12. Management and outcome of patients with malignant salivary gland tumors.
Bell RB; Dierks EJ; Homer L; Potter BE
J Oral Maxillofac Surg; 2005 Jul; 63(7):917-28. PubMed ID: 16003616
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemoradiation does not improve survival in elderly patients with high-risk resected head and neck cancer.
Giacalone NJ; Qureshi MM; Mak KS; Kirke D; Patel SA; Shah BA; Salama AR; Jalisi S; Truong MT
Laryngoscope; 2018 Apr; 128(4):831-840. PubMed ID: 28833217
[TBL] [Abstract][Full Text] [Related]
14. Treatment sequence and survival in locoregionally advanced hypopharyngeal cancer: A surveillance, epidemiology, and end results-based study.
Hochfelder CG; McGinn AP; Mehta V; Castellucci E; Kabarriti R; Ow TJ
Laryngoscope; 2020 Nov; 130(11):2611-2621. PubMed ID: 31821572
[TBL] [Abstract][Full Text] [Related]
15. Treatment of squamous cell carcinoma of external auditory canal: A tertiary cancer centre experience.
Gandhi AK; Roy S; Biswas A; Raza MW; Saxena T; Bhasker S; Sharma A; Thakar A; Mohanti BK
Auris Nasus Larynx; 2016 Feb; 43(1):45-9. PubMed ID: 26165629
[TBL] [Abstract][Full Text] [Related]
16. Outcome of surgery and post-operative radiotherapy for major salivary gland carcinoma: ten year experience from a single institute.
Kaur J; Goyal S; Muzumder S; Bhasker S; Mohanti BK; Rath GK
Asian Pac J Cancer Prev; 2014; 15(19):8259-63. PubMed ID: 25339015
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy and overall survival in adult medulloblastoma.
Kann BH; Lester-Coll NH; Park HS; Yeboa DN; Kelly JR; Baehring JM; Becker KP; Yu JB; Bindra RS; Roberts KB
Neuro Oncol; 2017 Feb; 19(2):259-269. PubMed ID: 27540083
[TBL] [Abstract][Full Text] [Related]
18. Primary Surgery vs Chemoradiation Treatment of Advanced-Stage Hypopharyngeal Squamous Cell Carcinoma.
Harris BN; Biron VL; Donald P; Farwell DG; Luu QC; Bewley AF; Chen AM; Daly ME
JAMA Otolaryngol Head Neck Surg; 2015 Jul; 141(7):636-40. PubMed ID: 25973578
[TBL] [Abstract][Full Text] [Related]
19. Is there a role of adjuvant treatment for salivary duct carcinoma?
Nakashima T; Yasumatsu R; Toh S; Hashimoto K; Shinoto M; Nakamura K; Komune S
J Laryngol Otol; 2015 Mar; 129 Suppl 2():S98-101. PubMed ID: 25706173
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
